Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment
开发大脑类器官来研究 HIV-1、滥用药物和衰老对认知障碍的影响
基本信息
- 批准号:10208846
- 负责人:
- 金额:$ 73.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-15 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalAddressAdultAffectAgeAgingAlkaloidsAutologousBioinformaticsBrainBrain regionCCL2 geneCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCell Culture TechniquesCell LineCell physiologyCellsCellular ImmunologyCerebral cortexCerebrumCicatrixCocaineComplexCytotoxic T-LymphocytesDementiaDevelopmentDisease modelDrug AddictionDrug ScreeningEffectivenessEffector CellEngineeringExhibitsExposure toFOXO3A geneGene ExpressionGene Expression ProfileGenesGenetic TranscriptionGoalsHIVHIV-1HIV-associated neurocognitive disorderHealthcare SystemsHeterogeneityHippocampus (Brain)HumanImageImmuneImpaired cognitionIn VitroIndividualInfectionInterdisciplinary StudyInterleukin-1 betaInternetLeadLinkMediatingMethodsMicrogliaMicroscopyModelingMolecular VirologyNervous System TraumaNeurocognitive DeficitNeuroectodermNeurogliaNeuronsOrganoidsPathogenesisPathway interactionsPeripheral Blood Mononuclear CellPharmaceutical PreparationsPhenotypeProcessProsencephalonReporterReproducibilityResidual stateRewardsRoleSignaling ProteinSteroidsStructureSubstance abuse problemSystemTNF geneTechnologyTestingToxic effectVariantViral ProteinsVirusaging brainanalogantiretroviral therapycell behaviorcell killingcognitive testingcombinatorialcortistatindrug of abusehindbraininduced pluripotent stem cellinnovationinsightlongevity genemicroscopic imagingmouse modelneural networkneuroimmunologyneuroinflammationneurotoxicitynonhuman primatenovelnovel strategiesnovel therapeuticssingle cell analysisstem cell technologystimulant abusetat Proteintranscriptometranscriptome sequencinguptake
项目摘要
PROJECT ABSTRACT
HIV-1 associated neuroinflammation and neurotoxicity lead to cognitive impairments (HIV-1-associated
neurocognitive disorders or HAND) even in those under suppressive antiretroviral therapy (ART). As people
living with HIV-1 age, a compounding effect is occurring, with age associated dementia added to HAND,
leading to a complex web of neurocognitive deficit. This will have tremendous implications for health care
systems not only in the USA but also in the developing world. How HAND develops, and how it could be
modified remain mysterious, largely because It has been very difficult to study HIV-1 infection and HAND in the
human brain. Over the past few years new developments in stem cell technologies have permitted the
differentiation of “cerebral organoids” from induced pluripotent stem cells (iPSCs), and these cultures can be
grown in vitro in conditions that promote three-dimensional expansion of neuroectoderm, in cerebral organoid
or “miniature brain” forms. Cerebral organoids are heterogeneous and form a variety of brain regions, including
ventral forebrain, cerebral cortex, hippocampus, and mid- and hindbrain boundary. They exhibit neurons that
are functional and capable of electrical excitation, and develop microglia. These brain organoids also resemble
human cortical development at the gene expression level, and allow in depth analysis of neural networks, cell
behavior, drug screening, disease modeling, and variations in brain development. While brain-region
composition varies in organoids from different iPSC lines, regional gene-expression patterns remain largely
reproducible across individuals. These create unparalleled new opportunities to study HIV-1 infection of the
brain. We propose to develop our iPSC derived organoid model which incorporates microglia, into one that
better represents an adult mature brain that can support robust HIV-1 infection. With this model, we can test
whether different viruses lead to differential neurotoxicity and if cells other than microglia can be latently
infected with virus. We will test how individual proteins from the virus, including HIV-1 Tat causes neurological
damage, and how ART or drugs such as Didehydro-Cortistatin A (dCA), which cross-neutralizes Tat activity,
affects the process. Interestingly, exposure to Tat also potentiates cocaine-mediated reward mechanisms,
which further promotes HAND, revealing a complex web of interactions between HIV-1 infection and drugs of
substance abuse. We will determine how Tat and cocaine collaborate in neurological damage and determine if
dCA can reverse it. As cerebral organoids provide a model for HIV-1 latency in the brain we can test whether
administration of dCA, can “block-and-lock” any residual virus, and finally whether HIV-1 specific cytotoxic T
cells (CTL) can eliminate virus in the organoid. Together, these studies promise to provide novel insights into
the pathogenesis of HAND, Tat mediated neurotoxicity, effects of cocaine, and the potential link between these
processes. Finally, the model promises to add exciting findings on HIV-1 latency in the brain, and if it can be
silenced or eliminated.
项目摘要
HIV-1相关的神经炎症和神经毒性导致认知障碍(HIV-1相关的神经毒性)。
神经认知障碍或HAND),甚至在那些处于抑制性抗逆转录病毒疗法(ART)下的患者中。随着人们
与HIV-1年龄一起生活,正在发生复合效应,与年龄相关的痴呆症增加到HAND,
导致复杂的神经认知缺陷这将对医疗保健产生巨大的影响
不仅在美国,而且在发展中国家。HAND如何发展,以及它如何成为
修改仍然是神秘的,主要是因为它一直是非常困难的研究HIV-1感染和手在
人脑在过去的几年里,干细胞技术的新发展使人们能够在干细胞领域中发挥重要作用。
诱导多能干细胞(iPSC)分化为“脑类器官”,并且这些培养物可以是
在促进神经外胚层三维扩张的条件下体外生长,
或“微型大脑”形式。大脑类器官是异质的,形成各种大脑区域,包括
腹侧前脑、大脑皮层、海马和中脑和后脑边界。它们的神经元
是功能性的,能够电兴奋,并发展小胶质细胞。这些脑类器官也类似于
在基因表达水平上研究人类皮层发育,并允许深入分析神经网络、细胞
行为,药物筛选,疾病建模,以及大脑发育的变化。而脑区
不同iPSC系的类器官组成不同,区域基因表达模式在很大程度上仍然存在
可在个体间复制。这为研究艾滋病病毒感染创造了前所未有的新机会。
个脑袋我们建议开发我们的iPSC衍生的类器官模型,该模型包含小胶质细胞,
更好地代表了一个成年人的成熟大脑,可以支持强大的HIV-1感染。有了这个模型,我们可以测试
不同的病毒是否导致不同的神经毒性,以及小胶质细胞以外的细胞是否可以潜伏
感染了病毒我们将测试病毒中的单个蛋白质,包括HIV-1达特如何引起神经系统疾病。
损伤,以及ART或药物如双脱氢皮质抑素A(dCA),交叉中和达特活性,
影响了进程。有趣的是,接触达特也能增强可卡因介导的奖赏机制,
这进一步促进了HAND,揭示了HIV-1感染和药物之间复杂的相互作用网络,
滥用药物我们将确定达特和可卡因在神经损伤中是如何合作的,
由于大脑类器官提供了HIV-1在大脑中潜伏的模型,我们可以测试是否
给予dCA,可以“阻断和锁定”任何残留的病毒,最后是否HIV-1特异性细胞毒性T
细胞(CTL)可以清除类器官中的病毒。总之,这些研究有望提供新的见解,
HAND的发病机制,达特介导的神经毒性,可卡因的作用,以及这些之间的潜在联系
流程.最后,该模型有望增加关于HIV-1在大脑中潜伏期的令人兴奋的发现,如果可以的话,
沉默或消灭。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOUGLAS F NIXON其他文献
DOUGLAS F NIXON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOUGLAS F NIXON', 18)}}的其他基金
The Role of Transposable Elements in Healthy Aging and in Alzheimer's Disease
转座元件在健康衰老和阿尔茨海默病中的作用
- 批准号:
10670482 - 财政年份:2022
- 资助金额:
$ 73.49万 - 项目类别:
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment
开发大脑类器官来研究 HIV-1、滥用药物和衰老对认知障碍的影响
- 批准号:
10398244 - 财政年份:2020
- 资助金额:
$ 73.49万 - 项目类别:
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment
开发大脑类器官来研究 HIV-1、滥用药物和衰老对认知障碍的影响
- 批准号:
10063343 - 财政年份:2020
- 资助金额:
$ 73.49万 - 项目类别:
Genetic Risk of HIV Acquisition: Mechanisms of Resilience
感染艾滋病毒的遗传风险:恢复机制
- 批准号:
10077116 - 财政年份:2020
- 资助金额:
$ 73.49万 - 项目类别:
Development of Brain Organoids to Study the Impact of HIV-1, Drugs of Abuse and Aging on Cognitive Impairment
开发大脑类器官来研究 HIV-1、滥用药物和衰老对认知障碍的影响
- 批准号:
10613440 - 财政年份:2020
- 资助金额:
$ 73.49万 - 项目类别:
Genetic Risk of HIV Acquisition: Mechanisms of Resilience
感染艾滋病毒的遗传风险:恢复机制
- 批准号:
10251347 - 财政年份:2020
- 资助金额:
$ 73.49万 - 项目类别:
Elimination of HIV using HERV specific T cells
使用 HERV 特异性 T 细胞消除 HIV
- 批准号:
9744988 - 财政年份:2019
- 资助金额:
$ 73.49万 - 项目类别:
HIV induced anti-cancer HERV immunity in prostate, breast and colon cancers
HIV 诱导前列腺癌、乳腺癌和结肠癌中的抗癌 HERV 免疫
- 批准号:
9129387 - 财政年份:2016
- 资助金额:
$ 73.49万 - 项目类别:
BELIEVE: Bench to Bed Enhanced Lymphocyte Infusions to Engineer Viral Eradication
相信:从床到床增强淋巴细胞输注可实现病毒根除
- 批准号:
9315726 - 财政年份:2016
- 资助金额:
$ 73.49万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 73.49万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 73.49万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 73.49万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 73.49万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 73.49万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 73.49万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 73.49万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 73.49万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 73.49万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 73.49万 - 项目类别:
Research Grant